PR: Corporate Reputation Building

Newlink logo

Overcoming Headwinds: the Evolving NewLink Genetics Image

  • Position NewLink Genetics as a player in immuno-oncology in a crowded field
  • Create visibility and awareness for clinical data across key stakeholders
  • Obtain validation for novel MOA for NLNK IDO pathway inhibitor, despite industry headwinds
  •  Thought leadership programming in the immuno-oncology space
  • Medical/Scientific meeting support
  • KOL and spokesperson message and media trainining
  • Coverage in top-tier financial and trade media based on ongoing data and unique MOA
  • Develop and implement strategy and evergreen content for NLNK social channels
  • Develop management spokespersons for thought leadership through LHS speaker training
  • Digital story-telling with Key Opinion Leaders and patient spokespersons
  • Increased positive “Share of Voice” for NewLink Genetics 
    • Thought leader roles at leading biotech and investor conferences
    • Featured KOLs in prominent oncology video and trade publications
    • Top-tier financial, national and trade coverage
    • Social amplification of programs, thought leadership, non-branded advocacy, and video assets
  • Increased understanding of company’s path forward